Skip to content

Clinical trials

Active, not recruiting Overweight trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Active, not recruiting Country / region: Canada Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20201
20211
20221
20232
20259
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Amgen3
Pfizer3
Novo Nordisk A/S2
AstraZeneca1
Boehringer Ingelheim1
Brock University1
John Sievenpiper1
University of Toronto1
University of Victoria1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity19
Overweight19
Body Weight4
Diabetes Mellitus, Type 24
Diabetes Mellitus2
Non-alcoholic Fatty Liver Disease2
Nutrition Disorders2
Nutritional and Metabolic Diseases2
Overnutrition2
Cardiovascular Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.